The page is the record's research on the issuer — no analyst, no rating, no view.

# Matinas BioPharma Holdings, Inc. (NYSE: MTNB) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

The issuer is Matinas BioPharma Holdings, Inc., listed on NYSE under ticker MTNB. The LEI is 549300TGHXVKQ7EJRO41. The ISIN is not on the record; several US ISINs are on the LEI: US5768101058, US5768102049, US5768103039 and US5768104029. The security type is Corporate. The segment is not on the record. The sector is 2834 Pharmaceutical Preparations. The jurisdiction is United States, Delaware. The issuer is listed and not halted.

## The disclosure read

The record holds 32 filings in the twelve months to 2026-11-08, across 26 filing days. The median gap between filing days is 7 days. The latest filing is dated 2026-11-06 and is of type directors_dealings, 2 days before the record date. The NYSE median cadence gap is 6.0 days, the NYSE median filings count is 64.0, and the NYSE median latency is 4.0 days. The 2834 Pharmaceutical Preparations sector median cadence gap is 6.0 days, its median filings count is 63.0, and its median latency is 4.0 days.

## Auditor

The auditor of record is EisnerAmper LLP, located in Iselin, New Jersey. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The issuer is listed and not halted.

## Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

## Coverage

No research houses were found on the issuer's investor-relations pages read. The count is 0.

## Open research

No openly published research notes were found on the record. The count is 0.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

## Sources

8 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://data.sec.gov/submissions/CIK0001582554.json (identity.jurisdiction)
- https://api.gleif.org/api/v1/lei-records/549300TGHXVKQ7EJRO41 (identity.lei)
- https://mcp.us-cm-kg.ai/events/NYSE/MTNB (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://www.sec.gov/Archives/edgar/data/1582554/000149315226014132/form10-k.htm (the auditor)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://mcp.us-cm-kg.ai/record/NYSE/MTNB (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NYSE/MTNB · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp
